Nintedanib for Improving Reproductive Outcomes in Adenomyosis

NCT07162961 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

328

Enrollment

OTHER

Sponsor class

Conditions

Adenomyosis of Uterus

Interventions

DRUG: Nintedanib
DRUG: Progesterone

Sponsor

Sun Yat-sen University